Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 98,427 | 90,122 | 92,055 | 101,907 | 152,915 |
| Cost of Goods | 30,686 | 33,768 | 21,635 | 24,897 | 19,477 |
| Gross Profit | 67,741 | 56,354 | 70,420 | 77,010 | 133,438 |
| Operating Expenses | 173,625 | 320,806 | 447,221 | 524,010 | 559,026 |
| Operating Income | -105,198 | -263,684 | -376,166 | -446,103 | -425,111 |
| Interest Expense | 28,112 | 25,334 | 28,911 | 47,313 | 37,118 |
| Other Income | 14,110 | 12,762 | 40,094 | -29,864 | 18,282 |
| Pre-tax Income | -119,200 | -276,256 | -364,983 | -523,280 | -443,947 |
| Income Tax | -239 | -200 | 3,215 | 557 | 493 |
| Net Income Continuous | -118,961 | -276,056 | -368,198 | -523,837 | -444,440 |
| Net Income | $-118,961 | $-276,056 | $-368,198 | $-523,837 | $-444,440 |
| EPS Basic Total Ops | -8.70 | -21.74 | -29.54 | -42.88 | -37.33 |
| EPS Basic Continuous Ops | -8.67 | -21.78 | -29.50 | -42.85 | -37.31 |
| EPS Diluted Total Ops | -8.70 | -21.74 | -29.54 | -42.88 | -37.33 |
| EPS Diluted Continuous Ops | -8.67 | -21.78 | -29.50 | -42.85 | -37.31 |
| EPS Diluted Before Non-Recurring Items | -10.50 | -12.89 | -29.54 | -42.88 | -33.58 |
| EBITDA(a) | $-100,807 | $-179,368 | $-363,136 | $-431,957 | $-410,929 |